Industries

The regulatory technology market in life sciences has, over the last five years, quietly transformed from a back-office category dominated by document repositories and submission publishing tools to one of the most consequential software segments serving the pharmaceutical, biotech, and medical device industries. What started in the late 1990s as a...

The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) spotlights a diverse slate of innovations across advanced medical devices, artificial intelligence solutions, wearables and drug delivery solutions.The issue features advanced medical devices such as non-invasive bimodal neuromodulation, surgical aesthetics platform for compre...

Neuromodulation is increasingly recognized as an effective method for managing chronic conditions and improving patients’ quality of life, gaining momentum as a cost-efficient, long-term treatment for neurological and nerve-related disorders. The prevalence of neurological disorders and nerve injuries, an aging population, and increasing government...

The global healthcare cybersecurity market is entering a new phase of growth as cyber risk becomes directly linked to patient safety, care continuity, and operational resilience. Healthcare organizations are expanding digital infrastructure across cloud environments, connected medical devices, patient-facing applications, and interoperable care eco...

The global POCT market is rapidly evolving from standalone rapid diagnostics to connected, AI-enabled clinical intelligence ecosystems that support decentralized healthcare delivery. Growth is driven by the increasing demand for faster clinical decision-making, early disease detection, personalized treatment, and expanded access to testing across h...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations reshaping drug discovery, diagnostics, and therapeutic delivery across oncology, infectious diseases, rare and autoimmune disorders, metabolic and age-related conditions, neurodegenerative and neuromu...

Rare diseases pose a global burden to healthcare despite making up a very small fraction of the global disease landscape. Most treatment options for rare diseases focus on maintaining the disease symptoms, rather than a disease-modifying approach. To address this unmet need, RNA therapies are emerging as disease-modifying approaches addressing the ...

The report explores the transformation of obesity care from generalized BMI-based treatment to AI-enabled precision metabolic management. The study highlights how obesity is increasingly recognized as a heterogeneous, multi-pathway disease influenced by genetic, neurobehavioral, metabolic, and environmental factors, requiring personalized therapeut...

This research study evaluates the evolving global digital therapeutics (DTx) ecosystem, with a focused analysis on Cognitive DTx and Metabolic DTx. The study examines the transition of DTx from emerging digital health tools toward clinically validated, interoperable, and scalable therapeutic platforms integrated within broader healthcare ecosystems...